Chi-jen Chu
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
A randomized trial of viral vector and adjuvanted protein HBV therapeutic vaccine in people with chronic hepatitis B on nucleos(t)ide analogs.
Journal: Hepatology communications
Published: March 20, 2026
Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma.
Journal: Clinical and experimental medicine
Published: November 08, 2024
Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma.
Journal: Clinical and molecular hepatology
Published: February 09, 2024
Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients.
Journal: Journal of the Chinese Medical Association : JCMA
Published: January 05, 2024
The Risk Factors and Clinical Outcomes in Hepatitis B Seropositive and Seronegative Renal Transplant Patients.
Journal: American journal of nephrology
Published: November 19, 2023
Prognostic Nutritional Index as a Prognostic Factor for Very Early-Stage Hepatocellular Carcinoma.
Journal: Clinical and translational gastroenterology
Published: September 26, 2023
The outcomes and prognostic factors of patients with hepatocellular carcinoma and Child-Turcotte-Pugh class B.
Journal: Journal of the Chinese Medical Association : JCMA
Published: August 04, 2023
Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response.
Journal: Journal of the Chinese Medical Association : JCMA
Published: July 19, 2023
The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: July 04, 2022
Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma.
Journal: Therapeutic advances in medical oncology
Published: December 02, 2021
Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis.
Journal: Journal of the Chinese Medical Association : JCMA
Published: November 11, 2021
Implementation and experience of an innovative smart patient care system: a cross-sectional study.
Journal: BMC health services research
Published: August 07, 2021
Last Updated: 09/26/2026